Next-Gen Oncopathology Program
Next-Gen Oncopathology Program
批准号:
10676213
负责人:
ETHEL CESARMAN
金额:
$36.18万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Next-Gen Oncopathology (NGO) program has the overall mission of training young diagnosticians to meet
advances in our understanding of the mechanisms of cancer pathogenesis and new oncological interventional
approaches thereby leading the field of pathology into the future. Specialized pathologists have been involved
in cancer diagnostics by examining tissues and other specimens since at least the 19th century, and training in
pathology has been incrementally structured and subspecialized. Pathology training programs traditionally teach
residents to examine tissue under the microscope and analyze laboratory data for diagnosis, with pathology
research being largely descriptive. This approach is no longer sufficient, and it is essential that we prepare
pathologists to understand and apply advanced technologies to perform more precise and personalized
diagnostics in addition to utilizing innovative and improved ways to conduct research and diagnose cancer. The
Weill Cornell Department of Pathology and Laboratory Medicine has trained numerous outstanding pathologists
in many subspecialty areas, but it is only with the use of an innovative approach incorporating a view towards
the future that we will be able to produce leaders that will advance the field of cancer pathology. The NGO
program takes a holistic and multidisciplinary approach, where all aspects of a cancer patient are considered,
ranging from the tumors themselves, to in vitro and in vivo cancer models, to changes in the patients’ blood and
microbial infections. Thus, trainees in both Anatomic and Clinical Pathology (i.e. Laboratory Medicine) will be
included, which will be individuals with MD or MD/PhD degrees doing a Pathology Residency or Fellowship, or
trainees with PhD degrees doing a clinical fellowship in Laboratory Medicine, who are committed to an academic
career that includes cancer research. Our trainees will gain expertise and depth by spending two years in a
research laboratory working in one or more of the following major themes: 1) molecular diagnosis and cellular
therapies, 2) cancer pathobiology, 3) advanced imaging and 4) tumor microenvironment. The foundational
principles of the NGO program will be to ensure that all the pathology projects relate to the study of cancer
patient samples as well as the comparative pathology of cancer models. Overarching methodologies that will
support all of the projects are: i) biostatistics and data science, ii) machine learning and artificial intelligence, and
iii) genomics, epigenomics, proteomics and metabolomics. Faculty in the program have expertise in the major
themes and specific methodologies, which will allow for the teaching of foundational skills as well as a highly
customized educational plan. This will be accomplished by the establishment of a mandatory NGO Course as
well as additional course requirements on data science and career development, which will allow trainees
flexibility to design a personalized curriculum with their mentoring committee. We will also leverage the Meyer
Cancer Center and the Weill Cornell Clinical and Translational Science Center (CTSC) resources to educate the
next generation of pathologists working on cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
-
批准号:10592130
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2023
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10416778
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10642906
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10541734
-
项目类别:
-
资助金额:$86.4万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10701826
-
项目类别:
-
资助金额:$82.78万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10228431
-
项目类别:
-
资助金额:$120.03万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10616708
-
项目类别:
-
资助金额:$117.81万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10398963
-
项目类别:
-
资助金额:$117.86万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10737765
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10397107
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10532587
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10617688
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10165675
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10405468
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:9893726
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10671507
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10454959
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10618368
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents
-
批准号:9763269
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Targeting vFLIP for the treatment of KSHV-associated malignancies
-
批准号:8433482
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2011
-
负责人:ETHEL CESARMAN
-
依托单位:
海外基金